Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial by Mitsudomi Tetsuya, Morita Satoshi, Yatabe Yasushi, Negoro Shunichi, Okamoto Isamu, Tsurutani Junji, Seto Takashi, Satouchi Miyako, Tada Hirohito, Hirashima Tomonori, Asami Kazuhiro, Katakami Nobuyuki, Takada Minoru, Yoshioka Hiroshige, Shibata Kazuhiko, Kudoh Shinzoh, Shimizu Eiji, Saito Hiroshi, Toyooka Shinichi, Nakagawa Kazuhiko, Fukuoka Masahiro, West Japan Oncology Group in The lancet oncology (2010).

[PMID: 20022809] PubMed

Abstract

Discussed In Paper

Loading...

Variant Annotations

Sign in to see variant annotations.

Dosing Information

No dosing information annotated.